Asia FX weakens slightly, rupee recovers from record low as RBI holds rates
Mirion Technologies , Inc. (NYSE:MIR), a $4.18 billion market cap company with $870.2 million in annual revenue, announced a refinancing of its credit agreement, as detailed in a recent SEC filing. On Thursday, the company entered into Amendment No. 5 to its existing Credit Agreement, originally dated October 20, 2021. This amendment introduces a new $450 million tranche of term loans set to mature in 2032.
The new tranche, known as the Replacement Term Loans, will be used to refinance all existing term loans under the current agreement. The interest rates for these loans are set at 2.25% for Term SOFR Loans and 1.25% for ABR Loans. The rates are subject to a 25 basis point reduction if Mirion achieves and maintains a Ba3 corporate rating from Moody’s and a BB- rating from S&P. The loans include a SOFR credit spread adjustment and a floor of 0.00%.
The amendment also provides Mirion with increased flexibility in financial operations. This includes more lenient terms for paying dividends, making investments, and incurring additional debt and liens. The loans are subject to a 1% prepayment premium if a repricing transaction occurs within six months. With the stock trading near its 52-week high and showing a remarkable 90.56% return over the past year, InvestingPro analysis suggests the stock may be overvalued at current levels.
The company’s corporate headquarters is located in Atlanta, Georgia. This information is based on a press release statement filed with the SEC.
In other recent news, Mirion Technologies reported impressive financial results for the first quarter of 2025, surpassing Wall Street expectations. The company posted an adjusted earnings per share (EPS) of $0.10, beating the forecast of $0.08, while revenue reached $202 million, slightly above the anticipated $199.34 million. This performance reflects a 6% year-over-year revenue growth, driven by strong segments such as Nuclear Safety and Nuclear Power. Additionally, Mirion Technologies announced plans to offer $300 million in Convertible Senior Notes due 2030, aiming to use the proceeds for strategic actions like repaying loans and stock repurchases. The offering will be contingent on market conditions, with no guarantee of completion. Furthermore, Mirion recently acquired a small software business called OncoSpace, enhancing its radiation therapy software capabilities. Analyst firms have not yet issued any upgrades or downgrades related to Mirion Technologies. These recent developments indicate significant activity within the company, focusing on growth and strategic financial management.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.